BackBackEBIT of SHANGHAI RIGHTONGENE BIOTECHNOLOGY
Annual data
−30.00 M
0.00
30.00 M
60.00 M
90.00 M
Period
Value
Change
Change %
TTM
−25.79 M
−15.02 M
−139.47%
2023
−10.77 M
−83.42 M
−114.83%
2022
72.65 M
+46.32 M
+175.94%
2021
26.33 M
−11.73 M
−30.82%
2020
38.05 M
+6.83 M
+21.86%
2019
31.23 M
+4.14 M
+15.30%
Quarterly data
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−22.00 M
−11.00 M
0.00
11.00 M
22.00 M
Period
Value
Change
Change %
Q3 '24
−7.29 M
−7.96 M
−1.18 K%
Q2 '24
674.68 K
+4.63 M
-
Q1 '24
−3.95 M
+11.27 M
+74.04%
Q4 '23
−15.23 M
−15.59 M
−4.34 K%
Q3 '23
359.01 K
−6.87 M
−95.03%
Q2 '23
7.23 M
+10.36 M
-
Q1 '23
−3.13 M
−24.95 M
−114.36%
Q4 '22
21.82 M
+8.27 M
+61.07%